Andrew C. Terentis1, Shane R. Thomas2, Hong Cai2, Osamu Takikawa3, Aviva Levina4, Peter A. Lay4, Mohammed Freewan2, and Roland Stocker2. (1) Florida Atlantic University, Boca Raton, FL, (2) University of New South Wales, Sydney, Australia, (3) National Center for Geriatrics and Gerontology, Obu, Japan, (4) University of Sydney, Sydney, Australia
The heme protein indoleamine 2, 3-dioxygenase (IDO) is induced by the pro-inflammatory cytokine interferon-γ (IFNγ) and plays an important role in the immune response by catalyzing the oxidative degradation of L-tryptophan (L-Trp) that contributes to immune suppression and tolerance. Here we examined the mechanism by which nitric oxide (NO) inhibits human IDO activity. Exposure of IFNγ-stimulated human monocyte-derived macrophages (MDM) to NO donors had no material impact on IDO mRNA or protein expression, yet exposure of MDM or transfected Cos-7 cells expressing active IDO to NO donors resulted in reversible inhibition of IDO activity. NO also inhibited the activity of purified recombinant human IDO (rhIDO) in a reversible manner and this correlated with NO binding to the heme of rhIDO. Optical absorption and resonance Raman spectroscopy identified NO-inactivated rhIDO as a ferrous iron (FeII)-NO-Trp adduct. Stopped-flow kinetic studies revealed that NO reacted most rapidly with FeII rhIDO in the presence of L-Trp. These findings demonstrate that NO inhibits rhIDO activity reversibly by binding to the active site heme to trap the enzyme as an inactive nitrosyl-FeII enzyme adduct with L-Trp bound and O2 displaced. Reversible inhibition by NO may represent an important mechanism controlling the immune regulatory actions of IDO.